glp 1 agonist and blindness GLP-1 Receptor Agonists Research to Treat Overeating and Substance Use Disorders Mapping the effectiveness and risks
Description
It is not approved for any of these yet, but the intent is clearly broader metabolic health, not just weight loss
You may still be a candidate for the Fitish Microdosing program, a lower dose option for patients who want a gentler, cosmetic approach
Safe, drug-free, non-GMO, USA-made
It should be noted that while GLP-1 agonists positively impact metabolism upstream of the liver, this may not subsequently improve the fibrotic liver injury within the tested treatment duration
Factors such as stress reduction, sufficient quality sleep, and mindful eating amplify the hormone's beneficial effects
